New Oral Anticoagulants vs Warfarin in Kidney Transplant.

被引：0
|
作者：
Raslan, S. R. [1 ]
Alkortas, D. [2 ]
机构：
[1] King Faisal Specialist & Hosp Res Ctr, Pharmaceut Care, Riyadh, Saudi Arabia
[2] KFSH & RC, Riyadh, Saudi Arabia
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
442
引用
收藏
页码：526 / 526
页数：1
相关论文
共 50 条
  • [41] Trends in the utilization of warfarin and the new oral anticoagulants in atrial fibrillation patients
    Alalwan, Abdullah Abdulaziz
    Voils, Stacy A.
    Hartzema, Abraham
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 133 - 134
  • [42] The Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients Hospitalized With Acute Kidney Injury
    Harrsch, Felicia A.
    Walls, Jennifer L.
    Makkar, Kathleen M.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (08) : 925 - 930
  • [43] The Survival Benefit of a Third Kidney Transplant.
    Redfield, R.
    Wood, A.
    Abt, P.
    Levine, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 148 - 149
  • [44] Pulmonary function in children with a kidney transplant.
    Cransberg, Karlien
    Pijnenburg, Marielle
    Lunstroot, Maaike
    Comelissen, Marlies
    Lilien, Marc
    Davin, Jean Claude
    Van Hoeck, Koen
    Merkus, Peter
    Nauta, Jeroen
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 53 - 54
  • [45] Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study
    Jun, Min
    Scaria, Anish
    Andrade, Jason
    Badve, Sunil, V
    Birks, Peter
    Bota, Sarah E.
    Campain, Anna
    Djurdjev, Ognjenka
    Garg, Amit X.
    Ha, Jeffrey
    Harel, Ziv
    Hemmelgarn, Brenda
    Hockham, Carinna
    James, Matthew T.
    Jardine, Meg J.
    Levin, Adeera
    McArthur, Eric
    Ravani, Pietro
    Shao, Selena
    Sood, Manish M.
    Tan, Zhi
    Tangri, Navdeep
    Whitlock, Reid
    Gallagher, Martin
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (06) : 621 - 631
  • [46] A utility-based decision analysis model for treatment of type I diabetics with ESRD: Dialysis vs kidney transplant vs kidney-pancreas transplant.
    Douzdjian, V
    Bunke, CM
    Ferrara, D
    Silvestri, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3168 - A3168
  • [47] Influence of the First Graft Nephrectomy in the Evolution of Second Kidney Transplant. Early VS Late?
    Fernandez, A.
    Burgos, D.
    Alonso, A.
    Ruiz, J.
    Sanchez-Fructuoso, A.
    Gomez, E.
    Franco, A.
    Sanchez, J.
    Cantarell, C.
    Guirado, L.
    Rodriguez Benot, A.
    Jimenez, C.
    Lazaurica, R.
    Jimeno, L.
    Zarraga, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 109 - 109
  • [48] New oral anticoagulants in patients with chronic kidney disease
    Belmar Vega, Lara
    de Francisco, A. L. M.
    Bada da Silva, Jairo
    Galvan Espinoza, Luis
    Fernandez Fresnedo, Gema
    NEFROLOGIA, 2017, 37 (03): : 244 - 252
  • [49] Influence of the First Graft Nephrectomy in the Evolution of Second Kidney Transplant. Early VS Late?
    Fernandez, A.
    Burgos, D.
    Alonso, A.
    Ruiz, J.
    Sanchez-Fructuoso, A.
    Gomez, E.
    Franco, A.
    Sanchez, J.
    Cantarell, C.
    Guirado, L.
    Rodriguez Benot, A.
    Jimenez, C.
    Lazaurica, R.
    Jimeno, L.
    Zarraga, S.
    TRANSPLANTATION, 2014, 98 : 109 - 109
  • [50] Warfarin or novel oral anticoagulants for atrial fibrillation?
    Larsen, Torben Bjerregaard
    Lip, Gregory Y. H.
    LANCET, 2014, 383 (9921): : 931 - 933
12345